The outcomes of treatment with gemtuzumab ozogamicin compared with those of conventional chemotherapy for relapse of acute myelogenous leukemia (AML) were studied. The gemtuzumab ozogamicin group ...

a AML = acute ... the gemtuzumab ozogamicin group (p < 0.0001). e p < 0.0001. f p < 0.0001. g p = 0.018. h NR = not reported (because of instability of model coefficients resulting from a high ...